Also trades as: UCB.BR (BRU) · $vol 55M · UCBJF (OTC) · $vol 0M

$115.22

+1.85 (+1.63%)

Weekly Expected Move ±4.2%

$106 $110 $115 $120 $125

OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $43.9B mcap · 120M float · 0.033% daily turnover · Short 29% of daily vol

Revenue

$7.4B +20.9% ▲

5Y CAGR: +6.8%

Gross Profit

$5.3B +20.2% ▲

5Y CAGR: +5.8%

Operating Income

$1.1B -15.4% ▼

5Y CAGR: +2.9%

Net Income

$1.5B +40.5% ▲

5Y CAGR: +15.4%

EPS (Diluted)

$3.86 +40.7% ▲

5Y CAGR: +15.4%

EBITDA

$1.7B -12.3% ▼

5Y CAGR: +5.8%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$5.8B	$5.5B	$5.3B	$6.2B	$7.4B
YoY Growth	+8.0%	-4.5%	-4.8%	+17.1%	+20.9%
Cost of Revenue	$1.4B	$1.7B	$1.7B	$1.8B	$2.1B
Gross Profit	$4.3B	$3.8B	$3.5B	$4.4B	$5.3B
Gross Margin	75.1%	69.6%	67.5%	71.5%	71.1%
R&D Expenses	$1.6B	$1.7B	$1.6B	$1.8B	$1.8B
SG&A Expenses	$1.6B	$1.7B	$1.8B	$2.3B	$2.4B
Operating Expenses	$3.1B	$3.2B	$2.9B	$3.1B	$4.2B
Operating Income	$1.3B	$585M	$604M	$1.3B	$1.1B
Operating Margin	22.2%	10.6%	11.5%	21.5%	15.1%
Interest Expense	$45M	$71M	$144M	$172M	$123M
Income Before Tax	$1.2B	$511M	$441M	$1.2B	$1.8B
Tax Expense	$170M	$91M	$98M	$98M	$254M
Net Income	$1.1B	$418M	$343M	$1.1B	$1.5B
Net Margin	18.3%	7.6%	6.5%	17.3%	20.1%
EPS (Diluted)	$2.73	$1.08	$0.88	$2.74	$3.86
EBITDA	$1.6B	$1.2B	$1.3B	$2.0B	$1.7B
Shares Outstanding	388M	390M	390M	389M	388M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$2.6B	$2.6B	$2.7B	$2.8B	$3.4B	$3.5B	$4.2B	$4.4B
Cost of Revenue	$925M	$901M	$1.0B	$851M	$901M	$922M	$1.2B	$1.1B
Gross Profit	$1.7B	$1.7B	$1.7B	$1.9B	$2.5B	$2.6B	$3.0B	$3.3B
Gross Margin	64.3%	65.2%	62.1%	69.5%	73.2%	73.6%	71.9%	74.6%
R&D Expenses	$872M	$759M	$871M	$789M	$992M	$860M	$955M	$931M
SG&A Expenses	$773M	$758M	$967M	$1.1B	$1.3B	$1.3B	$1.3B	$1.3B
Operating Expenses	$1.5B	$1.2B	$1.5B	$1.6B	$1.5B	$1.9B	$1.8B	$1.8B
Operating Income	$118M	$479M	$125M	$323M	$1.0B	$671M	$1.3B	$1.5B
Operating Margin	4.6%	18.5%	4.7%	11.6%	29.8%	19.2%	30.3%	33.3%
Interest Expense	$64M	$95M	$115M	$184M	-$12M	$0	$49M	$126M
Income Before Tax	$28M	$401M	$40M	$246M	$917M	$593M	$1.2B	$1.3B
Tax Expense	$9M	$90M	$8M	$38M	$60M	$118M	$145M	$198M
Net Income	$19M	$311M	$32M	$208M	$857M	$475M	$1.1B	$1.1B
Net Margin	0.7%	12.0%	1.2%	7.5%	25.5%	13.6%	25.5%	26.0%
EPS (Diluted)	$0.05	$0.80	$0.08	$0.54	$2.21	$1.22	$2.77	$2.92
EBITDA	$416M	$522M	$541M	$644M	$1.3B	$1.0B	$1.6B	$1.8B
Shares Outstanding	384M	389M	399M	390M	389M	389M	388M	388M

UCBJY OTC